CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-03 | McCourt Marion EVP Commercial | Sale 10b5-1 | −1,100 | $818.80 | $901K | 20,803 |
| 2023-04-03 | McCourt Marion EVP Commercial | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −1,100 | 4,450 | ||
| 2023-03-28 | Landry Robert E EVP Finance CFO | Sale 10b5-1 | −10 | $818.81 | $8K | 32,919 |
| 2023-03-28 | Landry Robert E EVP Finance CFO | Sale 10b5-1 | −115 | $820.85 | $94K | 32,804 |
| 2023-03-28 | Landry Robert E EVP Finance CFO | Sale 10b5-1 | −142 | $821.40 | $117K | 32,662 |
| 2023-03-28 | Landry Robert E EVP Finance CFO | Sale 10b5-1 | −128 | $822.67 | $105K | 32,534 |
| 2023-03-28 | Landry Robert E EVP Finance CFO | Sale 10b5-1 | −181 | $823.60 | $149K | 32,353 |
| 2023-03-28 | Landry Robert E EVP Finance CFO | Sale 10b5-1 | −157 | $824.54 | $129K | 32,196 |
| 2023-03-28 | Landry Robert E EVP Finance CFO | Sale 10b5-1 | −243 | $825.37 | $201K | 31,953 |
| 2023-03-28 | Landry Robert E EVP Finance CFO | Sale 10b5-1 | −31 | $826.36 | $26K | 31,922 |
| 2023-03-27 | Landry Robert E EVP Finance CFO | Option exercise 10b5-1 | +800 | $381.92 | $306K | 32,905 |
| 2023-03-27 | Landry Robert E EVP Finance CFO | Shares withheld for taxes 10b5-1 | −589 | $825.17 | $486K | 32,316 |
| 2023-03-27 | Landry Robert E EVP Finance CFO | Option exercise 10b5-1 | +3,000 | $378.98 | $1.1M | 35,316 |
| 2023-03-27 | Landry Robert E EVP Finance CFO | Shares withheld for taxes 10b5-1 | −2,204 | $825.17 | $1.8M | 33,112 |
| 2023-03-27 | Landry Robert E EVP Finance CFO | Sale 10b5-1 | −39 | $819.47 | $32K | 33,073 |
| 2023-03-27 | Landry Robert E EVP Finance CFO | Sale 10b5-1 | −50 | $820.46 | $41K | 33,023 |
| 2023-03-27 | Landry Robert E EVP Finance CFO | Sale 10b5-1 | −48 | $821.39 | $39K | 32,975 |
| 2023-03-27 | Landry Robert E EVP Finance CFO | Sale 10b5-1 | −18 | $822.57 | $15K | 32,957 |
| 2023-03-27 | Landry Robert E EVP Finance CFO | Sale 10b5-1 | −4 | $824.30 | $3K | 32,953 |
| 2023-03-27 | Landry Robert E EVP Finance CFO | Sale 10b5-1 | −13 | $825.59 | $11K | 32,940 |
Page 54 of 105 · 2,088 trades